Psychobiotic Supplements Market Size
The global Psychobiotic Supplements Market reached US$532.24 million in 2025 and is expected to reach US$2,628.00 million by 2033, growing at a CAGR of 21.20% during the forecast period 2026 to 2033.
Psychobiotics are a community of probiotics that impact the behaviors and related functions of the central nervous system mediated by the gut-brain axis through immune, neural, humoral, and metabolic pathways to improve gastrointestinal function, anxiolytic capacity, and the efficacy of antidepressants. The rising awareness of health and wellness drives the market for psychobiotic supplements.
Psychobiotic Supplements Market Scope
| Metrics | Details |
| CAGR | 21.20% |
| Size Available for Years | 2025-2033 |
| Forecast Period | 2026-2033 |
| Data Availability | Value (US$) |
| Segments Covered | Form, Application and Region |
| Regions Covered | North America, Europe, Asia-Pacific, South America and Middle East & Africa |
| Fastest Growing Region | Europe |
| Largest Region | North America |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report Request for Sample
Market Dynamics
The psychobiotic supplements market is emerging as a high-growth segment within the broader nutraceutical and mental wellness industry, driven by increasing awareness of the gut-brain axis and its impact on emotional and cognitive health. The rising prevalence of stress, anxiety, and depression is pushing consumers toward natural and preventive healthcare solutions, significantly boosting demand for psychobiotic products. Scientific advancements demonstrating the role of probiotics in producing neurotransmitters such as serotonin and GABA are strengthening consumer confidence and clinical adoption. Additionally, the growing popularity of functional foods, personalized nutrition, and clean label supplements, combined with expanding e-commerce distribution channels, is accelerating market penetration globally.
However, the market faces several challenges that could influence its long-term trajectory. Limited large-scale clinical validation and varying efficacy across different probiotic strains create skepticism among consumers and healthcare professionals. Regulatory issues with health claims, labeling, and the classification of psychobiotics make it even harder for the market to grow. In addition, high product costs, supply chain disruptions, and raw material price volatility pose barriers, especially in price-sensitive markets. Despite these challenges, continuous innovation in strain-specific formulations, advanced delivery technologies, and the integration of psychobiotics into personalized healthcare and telehealth platforms are expected to unlock significant growth opportunities, positioning the market for strong future expansion.
Competitive Landscape
The major global players include Lifted Naturals, Lallemand Health Solutions Inc., Uplift Food Pty Ltd., DuPont, BioGaia, Nature’s Bounty Co., Life Extension, Kerry Group, Bened Biomedical Co., Ltd. and NEURAXPHARM.
Recent Developments
In March 2026, rising awareness of the gut-brain axis and mental wellness accelerated demand for psychobiotic supplements, as consumers increasingly sought natural solutions for stress, anxiety, and cognitive health.
In February 2026, companies increased investments in personalized nutrition and targeted formulations, focusing on strain-specific psychobiotics designed for mood enhancement and stress management.
In January 2026, advancements in microbiome research and neuroscience integration supported the development of next-generation psychobiotic supplements with improved efficacy and stability.
In November 2025, emerging product launches highlighted the use of probiotic strains such as Lactobacillus and Bifidobacterium to support mental health through neurotransmitter regulation and reduced inflammation.
In October 2025, increasing focus on preventive healthcare and holistic wellness drove the adoption of psychobiotic supplements as part of broader gut health and functional nutrition trends.
In September 2025, rules and the need to prove effectiveness pushed companies to spend money on clinical studies and consistent product formulas, which helped build trust in the new psychobiotics market.
The global psychobiotic supplements market report would provide approximately 53 tables, 54 figures and 195 Pages
Target Audience
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
- Strategic consulting and market intelligence organizations.
- Research institutions focused on microbiome science, probiotics, nutrition, and mental health.
